- call +1-201-465-4211
- email sales@mrinsights.biz
Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine).
Scope of the Report:
The major symptoms associated with colorectal cancer include diarrhea, constipation, blood in feces, pain in abdomen, loss of appetite, loss of weight, nausea, vomiting, fatigue, lump in back passage, and iron deficiency in aged person.
The global Colorectal Cancer market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Colorectal Cancer.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Colorectal Cancer market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Colorectal Cancer market by product type and applications/end industries.
Market Segment by Companies, this report covers
Roche
Debiopharm
Merck Kgaa
Vaccinogen
Aeterna Zentaris
Keryx
Spectrum Pharmaceuticals
Mologen
Amgen
Bayer Healthcare
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Macroscopy
Microscopy
Immunochemistry
Staging
Tumor Budding
Market Segment by Applications, can be divided into
Hospitals and Clicnics
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Colorectal Cancer Market Overview
1.1 Product Overview and Scope of Colorectal Cancer
1.2 Classification of Colorectal Cancer by Types
1.2.1 Global Colorectal Cancer Revenue Comparison by Types (2017-2023)
1.2.2 Global Colorectal Cancer Revenue Market Share by Types in 2017
1.2.3 Macroscopy
1.2.4 Microscopy
1.2.5 Immunochemistry
1.2.6 Staging
1.2.7 Tumor Budding
1.3 Global Colorectal Cancer Market by Application
1.3.1 Global Colorectal Cancer Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals and Clicnics
1.3.3 Others
1.4 Global Colorectal Cancer Market by Regions
1.4.1 Global Colorectal Cancer Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Colorectal Cancer Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Colorectal Cancer Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Colorectal Cancer Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Colorectal Cancer Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Colorectal Cancer Status and Prospect (2013-2023)
1.5 Global Market Size of Colorectal Cancer (2013-2023)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Colorectal Cancer Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Colorectal Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.2 Debiopharm
2.2.1 Business Overview
2.2.2 Colorectal Cancer Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Debiopharm Colorectal Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck Kgaa
2.3.1 Business Overview
2.3.2 Colorectal Cancer Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Kgaa Colorectal Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.4 Vaccinogen
2.4.1 Business Overview
2.4.2 Colorectal Cancer Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Vaccinogen Colorectal Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.5 Aeterna Zentaris
2.5.1 Business Overview
2.5.2 Colorectal Cancer Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Aeterna Zentaris Colorectal Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.6 Keryx
2.6.1 Business Overview
2.6.2 Colorectal Cancer Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Keryx Colorectal Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.7 Spectrum Pharmaceuticals
2.7.1 Business Overview
2.7.2 Colorectal Cancer Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Spectrum Pharmaceuticals Colorectal Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.8 Mologen
2.8.1 Business Overview
2.8.2 Colorectal Cancer Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Mologen Colorectal Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.9 Amgen
2.9.1 Business Overview
2.9.2 Colorectal Cancer Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Amgen Colorectal Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.10 Bayer Healthcare
2.10.1 Business Overview
2.10.2 Colorectal Cancer Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Bayer Healthcare Colorectal Cancer Revenue, Gross Margin and Market Share (2016-2017)
3 Global Colorectal Cancer Market Competition, by Players
3.1 Global Colorectal Cancer Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Colorectal Cancer Players Market Share
3.2.2 Top 10 Colorectal Cancer Players Market Share
3.3 Market Competition Trend
4 Global Colorectal Cancer Market Size by Regions
4.1 Global Colorectal Cancer Revenue and Market Share by Regions
4.2 North America Colorectal Cancer Revenue and Growth Rate (2013-2018)
4.3 Europe Colorectal Cancer Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Colorectal Cancer Revenue and Growth Rate (2013-2018)
4.5 South America Colorectal Cancer Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Colorectal Cancer Revenue and Growth Rate (2013-2018)
5 North America Colorectal Cancer Revenue by Countries
5.1 North America Colorectal Cancer Revenue by Countries (2013-2018)
5.2 USA Colorectal Cancer Revenue and Growth Rate (2013-2018)
5.3 Canada Colorectal Cancer Revenue and Growth Rate (2013-2018)
5.4 Mexico Colorectal Cancer Revenue and Growth Rate (2013-2018)
6 Europe Colorectal Cancer Revenue by Countries
6.1 Europe Colorectal Cancer Revenue by Countries (2013-2018)
6.2 Germany Colorectal Cancer Revenue and Growth Rate (2013-2018)
6.3 UK Colorectal Cancer Revenue and Growth Rate (2013-2018)
6.4 France Colorectal Cancer Revenue and Growth Rate (2013-2018)
6.5 Russia Colorectal Cancer Revenue and Growth Rate (2013-2018)
6.6 Italy Colorectal Cancer Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Colorectal Cancer Revenue by Countries
7.1 Asia-Pacific Colorectal Cancer Revenue by Countries (2013-2018)
7.2 China Colorectal Cancer Revenue and Growth Rate (2013-2018)
7.3 Japan Colorectal Cancer Revenue and Growth Rate (2013-2018)
7.4 Korea Colorectal Cancer Revenue and Growth Rate (2013-2018)
7.5 India Colorectal Cancer Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Colorectal Cancer Revenue and Growth Rate (2013-2018)
8 South America Colorectal Cancer Revenue by Countries
8.1 South America Colorectal Cancer Revenue by Countries (2013-2018)
8.2 Brazil Colorectal Cancer Revenue and Growth Rate (2013-2018)
8.3 Argentina Colorectal Cancer Revenue and Growth Rate (2013-2018)
8.4 Colombia Colorectal Cancer Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Colorectal Cancer by Countries
9.1 Middle East and Africa Colorectal Cancer Revenue by Countries (2013-2018)
9.2 Saudi Arabia Colorectal Cancer Revenue and Growth Rate (2013-2018)
9.3 UAE Colorectal Cancer Revenue and Growth Rate (2013-2018)
9.4 Egypt Colorectal Cancer Revenue and Growth Rate (2013-2018)
9.5 Nigeria Colorectal Cancer Revenue and Growth Rate (2013-2018)
9.6 South Africa Colorectal Cancer Revenue and Growth Rate (2013-2018)
10 Global Colorectal Cancer Market Segment by Type
10.1 Global Colorectal Cancer Revenue and Market Share by Type (2013-2018)
10.2 Global Colorectal Cancer Market Forecast by Type (2018-2023)
10.3 Macroscopy Revenue Growth Rate (2013-2023)
10.4 Microscopy Revenue Growth Rate (2013-2023)
10.5 Immunochemistry Revenue Growth Rate (2013-2023)
10.6 Staging Revenue Growth Rate (2013-2023)
10.7 Tumor Budding Revenue Growth Rate (2013-2023)
11 Global Colorectal Cancer Market Segment by Application
11.1 Global Colorectal Cancer Revenue Market Share by Application (2013-2018)
11.2 Colorectal Cancer Market Forecast by Application (2018-2023)
11.3 Hospitals and Clicnics Revenue Growth (2013-2018)
11.4 Others Revenue Growth (2013-2018)
12 Global Colorectal Cancer Market Size Forecast (2018-2023)
12.1 Global Colorectal Cancer Market Size Forecast (2018-2023)
12.2 Global Colorectal Cancer Market Forecast by Regions (2018-2023)
12.3 North America Colorectal Cancer Revenue Market Forecast (2018-2023)
12.4 Europe Colorectal Cancer Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Colorectal Cancer Revenue Market Forecast (2018-2023)
12.6 South America Colorectal Cancer Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Colorectal Cancer Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Colorectal Cancer Picture
Table Product Specifications of Colorectal Cancer
Table Global Colorectal Cancer and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
